Latest disclosed round
Series B
- Date
- 2022-12-01
- Amount
- USD 30m
- Sector
- Biotech & techbio
- Companies House
- 09553473
Series B
Storm Therapeutics
RNA epigenetics (oncology)
CandidateSeries BCambridge
Evidence status
Review retained
- Identity
- Candidate
- Match
- High candidate
- Operating status
- active
- Data origins
- Core directory, Growth Network, Live Chris T D1
Capital network
8 linked investors
Funding record
1 disclosed round
| Date | Stage | Amount | Investors |
|---|---|---|---|
| 2022-12-01 | Series B | $30M | M Ventures, Pfizer Ventures, Taiho Ventures, Cambridge Innovation Capital, Fast Track Initiative, UTokyo Innovation Platform, Seroba Life Sciences, IP Group |
Traceability
Source trail
Funding and investor claims retain their public-source links. This is a research snapshot, not a live cap table.